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Autism-like phenotypes in male valproate (VPA)-exposed offspring have been linked
to high glutamatergic neurotransmission in the thalamic-amygdala pathway. Glial
cystine/glutamate exchange (system Xc−), which exchanges extracellular cystine for
intracellular glutamate, plays a significant role in the maintenance of extracellular
glutamate. N-acetylcysteine (NAC) is a cystine prodrug that restores extracellular
glutamate by stimulating system Xc−. In this study, we examined the effects of NAC
on autism-like phenotypes and neurotransmission in the thalamic–amygdala synapses,
as well as the involvement of metabotropic glutamate receptors 2/3 (mGluR2/3).
Valproate-treated rats received a single intraperitoneal injection of 500mg/kg NaVPA on
E12.5. On postnatal day 21 (P21), NAC or saline was administered once daily for 10 days.
From day 8 to 10, NAC was given 1/2 h prior to behavioral testing. Chronic administration of
NAC restored the duration and frequency of social interaction and ameliorated anxiety-like
behaviors in VPA-exposed offspring. In amygdala slices, NAC treatment normalized the
increased frequency of mEPSCs and decreased the paired pulse facilitation (PPF) induced
by VPA exposure. The effects of NAC on social interaction and anxiety-like behavior in the
VPA-exposed offspring were blocked after intra-amygdala infusion of mGluR2/3 antagonist
LY341495. The expressions of mGluR2/3 protein and mGluR2 mRNA were significantly
lower in the VPA-exposed offspring. In contrast, the mGluR3 mRNA level did not differ
between the saline- and VPA-exposed offspring. These results provide the first evidence
that the disruption of social interaction and enhanced presynaptic excitatory transmission
in VPA-exposed offspring could be rescued by NAC, which depends on the activation of
mGluR2/3.
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INTRODUCTION
Autism spectrum disorders (ASDs) are a group of clinically and
genetically heterogeneous neurodevelopmental disorders charac-
terized by social deficits, communication difficulties, stereotyped,
or repetitive behaviors and interests (Baird et al., 2006; Levitt
and Campbell, 2009). Several brain structures and pathways have
been suggested to underlie this disorder, including the amyg-
dala (Adolphs et al., 2001; Baron-Cohen and Belmonte, 2005).
Functional magnetic resonance imaging (fMRI) study has pro-
vided evidence of abnormality of the amygdala in autism (Baron-
Cohen et al., 1999, 2000). Altered amygdala activation in response
to facial and emotion processing has been noted in individuals
with ASD (Wang et al., 2004; Dalton et al., 2005; Hadjikhani et al.,
2007). Postmortem studies of individuals with ASD have shown
cyto-architectural and neuronal organization changes within the
amygdala (Bailey et al., 1998; Schumann and Amaral, 2006).
Structural MR imaging studies have also demonstrated abnor-
mal amygdala volumes both in adolescents and adults with ASD
(Aylward et al., 1999; Rojas et al., 2004; Nacewicz et al., 2006).
These results suggest that amygdala dysfunction may contribute
to core social impairment in ASD (Todd and Anderson, 2009).
Exposures to environmental toxicants that activate the
immune system have been implicated in ASD (Windham et al.,
2006; Roberts et al., 2007; Palmer et al., 2009). Rats with gesta-
tional exposure to lipopolysaccharide, an endotoxin that activates
the immune system, have been established as a prenatal infection
model for developmental neuropsychiatric disorders (Baharnoori
et al., 2012). Intra-cerebroventricular injection of propionic acid,
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a short chain fatty acid, has also been used to develop a rodent
model of ASD (Macfabe et al., 2007; Shultz et al., 2009; El-Ansary
et al., 2012; Foley et al., 2014). In clinical practice, valproate
(VPA), a short chain fatty acid, has been widely used for the treat-
ment of patients with epilepsy and mood disorder. However, the
offspring of women taking VPA medication during early preg-
nancy are at increased risk of ASD (Christensen et al., 2013;
Wood, in press). In a rat model of ASD, VPA-exposure offspring
exhibited several symptoms common to ASD and enhanced fear
learning memories (Markram et al., 2008).
The precise mechanisms by which VPA-exposure offspring
exhibit autism-like phenotypes are still not clear. In VPA-exposed
offspring, Tyzio et al. observed increased excitatory GABA, glu-
tamatergic activity and gamma oscillations in hippocampal CA3
neurons (Tyzio et al., 2014). Importantly, restoration of the
neuronal excitatory and inhibitory balance could rescue the
behavioral phenotypes. We have also observed enhanced long
term potentiation at the thalamic–amygdala synapses in VPA-
exposed offspring (Lin et al., 2013). Furthermore, treatment with
a 5-HT1A receptor agonist increased social interaction and also
reversed the characteristics of miniature excitatory post-synaptic
currents as well as paired pulse facilitation (PPF) observed in
lateral amygdala slices (Wang et al., 2013). A functional balance
between neuronal excitatory and inhibitory systems is established
during development (Eichler and Meier, 2008). Defects in the
ability to establish andmaintain the balance have been considered
to play a key role in the pathogenesis of ASD (Bateup et al., 2013).
In a genetic rodent model of ASD, autistic-like behaviors are also
accompanied by an increased ratio of excitatory to inhibitory
synaptic inputs in the medial prefrontal cortex, striatum, and
hippocampus (Gkogkas et al., 2013; Santini et al., 2013). These
studies indicated that excitatory/ inhibitory imbalances in key
brain regions could be associated with the behavioral phenotypes
of ASD.
N-acetylcysteine (NAC) is an antioxidant and a precursor of
glutathione that has been shown to rescue the brain from free
radical injury after focal cerebral ischemia (Khan et al., 2004).
NAC also reversed cognitive impairment and oxidative stress
in aged and Tg2576 mutant mice (Farr et al., 2003; Fu et al.,
2006; Parachikova et al., 2010). The antiporter system Xc−, which
belongs to the family of heterodimeric amino acid transporters,
imports the amino acid cystine into cells with a 1:1 counter-
transport of glutamate. NAC is an orally bioavailable prodrug
of cysteine that can be oxidized to cystine. After administration
of NAC, Xc− antiporter allows for the cellular uptake of cys-
tine, which causes the reverse transport of glutamate into the
extracellular space. The nonvesicular glutamate released into the
extracellular space stimulates the type 2/3 metabotropic gluta-
mate receptors (mGluR2/3), which, in turn, inhibit the vesicular
release of glutamate, thereby resulting in a decrease in gluta-
matergic neurotransmission (Baker et al., 2002). In clinical trials,
administration of NAC or a placebo in a blind fashion to a
group of children with autistic disorder supports the potential
usefulness of NAC for treating behavioral disturbance in chil-
dren with autism (Hardan et al., 2012). The purpose of this study
was to determine whether NAC normalizes the increased presy-
naptic transmitter release and decreased social interaction seen
in VPA-exposed offspring. We demonstrated that NAC reversed
abnormal behaviors and synaptic transmission in a VPA-induced
rat ASD model by acting on the mGluR2/3 receptors.
MATERIALS AND METHODS
ANIMALS
We used the valproate-induced rat model of autism. All proce-
dures were approved by the Institutional Animal Care and Use
Committee of the College of Medicine, National Cheng-Kung
University (Tainan, Taiwan). Sprague Dawley rats were housed
in groups of 3–4 per cage in a temperature-controlled (24◦C)
vivarium on a 12 h reverse light/dark cycle, with lights on at
7:00 AM. All behavioral procedures took place during the light
cycle. Rats were mated, with pregnancy determined by the pres-
ence of a vaginal plug on embryonic day 1 (E1). The sodium
salt of valproic acid (NaVPA, Sigma-Aldrich, MO, USA) was dis-
solved in 0.9% saline to obtain a concentration of 150mg/mL,
pH 7.3. Exposed dams received a single intraperitoneal injection
of 500mg/kg NaVPA adjusted according to body weight and con-
trol dams a single injection of saline on E12.5. Dams were housed
individually and were allowed to raise their own litters until wean-
ing. The offspring were then separated and housed in cages of 3–4
rats until the end of all behavioral experiments.
BEHAVIORAL TESTING
On postnatal day 21 (P21), NAC (150mg/kg, intraperitoneal
(i.p.); sigma) or saline was administered once daily for 10 days.
From day 8 to 10, NAC was given 1/2 h prior to behavioral
testing (Figure 1). The behavioral tests were analyzed in the
saline-exposed with vehicle (saline/saline), saline-exposed with
NAC (saline/NAC), VPA-exposed with vehicle (VPA/saline), or
VPA-exposed with NAC (VPA/NAC) offspring. The social inter-
action test, elevated plus-maze test and open field test were
conducted each day after NAC treatment. At the end of the
FIGURE 1 | The experimental design employed in the present study.
On postnatal day 21 (P21), NAC (150mg/kg, intraperitoneal (i.p.); sigma) or
saline was administered once daily for 10 days. From P28 to P30, the social
interaction test, elevated plus-maze test, and open field test were
conducted each day after NAC treatment. To elucidate whether the effect of
NAC on social interaction in VPA-exposed offspring is mediated by
mGluR2/3, on P24, the mGluR2/3 antagonist LY341495 (2µg/0.5µl/side)
was infused into the amygdala 30min before the administration of NAC
once per day for 5 days.
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elevated plus-maze test, the same offspring received either elec-
trophysiological recordings or were sacrificed for western blot-
ting. Video tracking software (Ethovision, Noldus, Netherlands)
was used for automatic recording and analysis of social
interaction.
Social interaction
Rats were separated and housed individually the night before
the experiment. The apparatus was a white plastic box (50 × 40
× 40 cm). Rats were matched in terms of age, gender, and weight.
After a 1-h habituation period in the room, one VPA-exposed
and one saline-exposed rat were placed into the apparatus over
a period of 20min. The percentage of time spent sniffing of any
body part, mounting, grooming each other, and following were
taken as indicators of social engagement (Flagstad et al., 2004).
Open field test
The rats were placed in a white plastic box (50 × 40 × 40 cm)
for 15min. The percentage of time spent in the central zone
(25% of the surface area) and the total distance (cm) moved were
measured.
Elevated plus-maze
The rats were placed in a standard elevated plus-maze for 5min,
which consisted of a plus-shaped apparatus with two opposite
open arms and two opposite enclosed arms (50 × 5 × 40 cm)
arranged at right angles. The percentage of time spent in each arm
and the total distance (cm) moved were measured.
BRAIN SLICE PREPARATION AND ELECTROPHYSIOLOGICAL
RECORDINGS OF THE AMYGDALA
Brain slices were prepared as described previously (Lin et al.,
2013). Whole-cell recordings were made from the soma of
visually-identified pyramidal-like neurons located in the LA.
Neurons were identified as projection neurons based on their
intrinsic electrophysiological properties (Washburn and Moises,
1992) in potassium gluconate-containing electrodes. The minia-
ture excitatory post-synaptic currents (mEPSCs) were recorded
in the presence of bicuculline (10µM; Tocris) and tetrodotoxin
(TTX, 5 M; Tocris). We also examined the PPF in slices from the
saline/saline, saline/NAC, VPA/saline, and VPA/NAC offspring.
The ratio of the amplitude of the first EPSC divided by the ampli-
tude of the second EPSC was examined at 30, 50, 150, and 200-ms
interpulse intervals.
SURGERY
Both saline-exposed and VPA-exposed offspring were anes-
thetized with 10% chloral hydrate (50mg/kg, i.p.). The mice were
mounted on a stereotaxic apparatus and cannulas (22 gauge stain-
less steel tubing) were implanted into the lateral amygdala (LA)
(anteroposterior, −2.3mm; mediolateral, ±5mm; dorsoven-
tral, −6.7mm). A 28-gauge dummy cannula was inserted into
each cannula to prevent clogging. The rats were monitored and
handled daily and were given 7 days to recover. The mGlu2/3
antagonist LY341495 (Tocris), dissolved in about 10µl of 0.1M
NaOH and brought to dose volume using 0.9% sterile saline
solution and adjusted to pH 7.4, was administered bilaterally to
the amygdala in a volume of 2µg/0.5µl per side at a rate of
0.1µl/min 30min before the last NAC administration and each
behavioral test. The infusion cannulas were left in place for 2min
before being withdrawn.
WESTERN BLOTTING ASSAY
After all behavioral tests, amygdala tissues were dissected from
the brains of rats of both groups. The amygdala tissues were
lysed in a lysis buffer containing 1% Triton X-100, 0.1% SDS,
50mM Tris-HCl, pH 7.5, 0.3M sucrose, 5mM EDTA, 2mM
sodium pyrophosphate, 1mM sodium orthovanadate, and 1mM
enylmethylsulfonyl fluoride, supplemented with complete pro-
tease inhibitor cocktail. Following sonication, the lysates were
centrifuged at 12,000 rpm for 30min to obtain supernatants.
The protein concentrations of the supernatants were mea-
sured using a Bradford assay, and equal amounts of protein
were separated by SDS-PAGE electrophoresis, transferred to
Immobilon-P membranes (Millipore), and incubated in 5%
nonfat dry milk for 60min. Western blot analysis involved
mGluR2/3 (1:1000; Abcam), Xc− (1:1000; Abcam) and Actin
(1:100000; Millipor) antibody reacted overnight at 4◦C and
incubated with HRP-conjugated secondary antibodies for 1 h
at room temperature. Immunoreactivity was detected by ECL
Plus detection reagent (PerkinElmer, Boston, MA). Films were
exposed at different times to ensure optimum density but
not saturation, followed by densitometry. Protein levels were
first normalized to internal control levels for each sample
and then measured as fold changes of those in the con-
trols, respectively. Three replicates were performed for each
experiment.
GRM2 AND GRM3 mRNA MEASUREMENT
A total RNA spin kit (Bioman) was used to extract total RNA
from amygdala tissues and the ImProm-II Reverse Transcription
System (Promega Madison, WT) was used to synthesize cDNA.
mRNAs of Grm2 and Grm3 were measured by TaqMan real-time
quantitative reverse transcription polymerase chain reaction (RT-
PCR) using a StepOnePlus™ System (Life Technologies). A Grm2
probe (Rn01447672_m1), Grm3 probe (Rn01755352_m1), and
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) probe
(Rn01775763_g1) were obtained from Life Technologies. The RT
reactions were performed as follows: 50◦C for 2min, 95◦C for
10min, followed by 40 cycles at 95◦C for 15 s and 1min at 60◦C.
The Gapdh gene was used as an endogenous control to standard-
ize the amount of sample RNA. The levels of Grm2 and Grm3
mRNA were first normalized to Gapdh mRNA for each sample
and then measured as fold changes of those in the controls.
STATISTICAL ANALYSIS
All values are given as mean ± s.e.m. Two-way ANOVA and
Newman–Keuls post-hoc comparisons were used to analyze the
differences in behavioral tests, electrophysiology responses and
protein levels of saline-exposed and VPA-exposed rats. The vari-
ables were assessed using Student’s t-test to analyze the differences
in mGlur2/3 antagonist effects and mRNA level among the con-
trols and the VPA-exposed group. The difference between groups
was considered significant if p < 0.05.
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RESULTS
EFFECTS OF NAC ON BEHAVIORAL PHENOTYPES OF VPA-EXPOSED
OFFSPRING
The rats were classified into saline/saline, saline/NAC, VPA/saline,
and VPA/NAC 4 groups. We first determined whether NAC had
any effect on social interaction deficit in male VPA-exposed off-
spring. The dose of NAC chosen was based on a previous report in
which NAC (150mg/kg) administered subcutaneously once daily
for 4 weeks improved the cognition of 12-month-old SAMP8
mice (Farr et al., 2003). As shown in Figure 2A, male VPA-
exposed offspring exhibited a lower duration of social interaction
than male saline-exposed offspring (p < 0.001). Importantly, the
deficit in social interaction was completely reversed after treat-
ment with NAC. Two-Way ANOVA revealed main effects of
pre-treatment [VPA vs. saline, F(1, 73) = 7.209, p < 0.01] and
drug [NAC vs. saline, F(1, 73) = 7.333, p < 0.01] and a significant
pre-treatment by drug interaction [F(1, 73) = 4.175, p < 0.05].
A similar result was observed for the frequency of interaction
(Figure 2B). Two-Way ANOVA revealed main effects of pre-
treatment [VPA vs. saline, F(1, 73) = 9.073, p < 0.01] and drug
[NAC vs. saline, F(1, 73) = 5.527, p < 0.05] and a significant pre-
treatment by drug interaction [F(1, 73) = 4.181, p < 0.05]. There
were no differences in either the interaction duration or frequency
between the saline/NAC and saline/saline groups. The results
indicated that chronic treatment with NAC could ameliorate the
social interaction deficits in the VPA-exposed offspring without
affecting the performance of the saline-exposed offspring.
To examine whether the VPA-exposed offspring exhibited
emotional alterations, the rats were tested with anxiety-like
FIGURE 2 | Reversal of the social interaction deficit in VPA-exposed
offspring by NAC. Rats of VPA- or saline-expose offspring weaned at
postnatal day 21 (P21) were used in this experiment. NAC (150mg/kg, i.p.)
or saline was administered once per day for 10 days (P21 to P30). On P28,
the male offspring were tested for social interaction. The duration (A) and
the frequency (B) of occurrence of various social behaviors such as sniffing,
mounting and grooming partner were measured in the VPA- and
saline-exposed offspring for 20min. Sample sizes (n): Saline/Saline n = 21,
Saline/NAC n = 5, VPA/Saline n = 25, VPA/NAC n = 17. ∗∗∗p < 0.001 vs.
VPA/NAC.
behavioral paradigms. In the EPM test, Two-Way ANOVA
revealed main effects of pre-treatment [VPA vs. saline, F(1, 73) =
15.27, p < 0.001] and drug [NAC vs. saline, F(1, 73) = 4.715,
p < 0.05] but no significant pre-treatment by drug interaction
[F(1, 73) = 1.872, p > 0.05] (Figure 3A). VPA-exposed offspring
exhibited less time spent in the open arms than saline-exposed
offspring (p < 0.001). NAC treatment restored the time spent in
the open arms. There was no difference in the distance traveled
(Figure 3B). In the open field test, Two-Way ANOVA revealed
main effects of pre-treatment [VPA vs. saline, F(1, 64) = 4.053,
p < 0.05] and drug [NAC vs. saline, F(1, 64) = 4.578, p < 0.05]
but no significant pre-treatment by drug interaction [F(1, 64) =
0.27, p > 0.5] (Figure 3C). The VPA-exposed offspring exhib-
ited less time spent in the center (p < 0.01), which was restored
after treatment with NAC. There was no difference in the distance
traveled (Figure 3D). These results suggest that VPA-exposed off-
spring exhibit anxiety-related behaviors that could be ameliorated
by NAC.
NAC MODULATES AMYGDALA SYNAPTIC ACTIVITY IN VPA-EXPOSED
OFFSPRING
We examined whether alteration of excitatory synaptic transmis-
sion in the VPA-exposed offspring could be normalized by NAC.
Amygdala slices were made 1 h after the behavioral tests and
whole-cell recordings weremade from the soma of visually identi-
fied pyramidal-like neurons located in the LA. Figure 4 shows that
saline/saline rats exhibited a significantly lower frequency ofmEP-
SCs than the VPA/saline group (p < 0.001). Two-Way ANOVA
revealed a significant main effect of pre-treatment [VPA vs. saline,
F(1, 24) = 25.35, p < 0.01] in the absence of a main effect of
drug [NAC vs. saline, F(1, 24) = 7.64, p = 0.0815] or a significant
pre-treatment x drug interaction [F(1, 24) = 8.36, p = 0.0698].
Post-hoc tests showed that the increased mEPSC frequency in the
VPA-exposed offspring was significantly reduced after treatment
with NAC (p < 0.01) (Figure 4B). The amplitudes of mEPSCs
did not differ among the four groups (Figure 4C).
We further analyzed the PPF in the four groups. As illustrated
in Figure 5, the PPF ratios at an interpulse interval of 30ms
were significantly lower in the VPA/saline group (1.03 ± 0.08,
n = 8) than in the saline/saline (1.50 ± 0.06, n = 6, p < 0.01)
rats. Administration of NAC restored the PPF ratio to a level com-
parable to that of the saline/saline group (1.68 ± 0.18, n = 8,
p < 0.01 vs. VPA/saline). Moreover, there was no difference in
the PPF between the saline/NAC and saline/saline groups. The
results suggested that NAC normalizes the increased presynaptic
transmitter release in the VPA-exposed offspring.
EFFECT OF NAC ON SOCIAL INTERACTION IN VPA-EXPOSED
OFFSPRING IS MEDIATED BY mGLuR2/3
NAC is a cystine prodrug that increases extracellular glutamate
by stimulating system Xc−, resulting in activation of presynap-
tic mGluR2/3 and thereby reducing synaptic glutamate release
(Baker et al., 2002). We tested this hypothesis by infusion of
the mGluR2/3 antagonist LY341495 (2µg/0.5µl/side) into the
amygdala 30min before the administration of NAC. Figure 6
shows that LY341495 reduced both the interaction duration
(Figure 6C) and frequency (Figure 6D) to the levels of 85.4 ±
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FIGURE 3 | Amelioration of anxiety in the VPA-exposed offspring by NAC.
OnP29 and P30, ratswere administered the elevated plus-maze test (EPM) and
the open field test (OF). In the EPM test, the time spent in the open arms (A)
and the distance traveled (B)were measured for 5min. ∗∗∗p < 0.001 vs.
VPA/NAC. In the OF test, the time spent in the center (C) and the distance
traveled (D)were measured for 15min. ∗∗p < 0.01 vs VPA/NAC.
15.5 s (n = 9) and 32.1 ± 2.3 (n = 9), respectively, which were
comparable to those of the VPA/saline (duration: 108.7 ± 14.9 s;
frequency: 25.1 ± 4.1, n = 27) rats. As a control experiment, we
also infused LY341495 into the amygdala in saline-exposed off-
spring. LY341495 had no effect on either the interaction duration
(Figure 6A) or frequency (Figure 6B). These results indicated
that LY341495 blocked the reversing effects of NAC on social
interaction.
Similar to the effects on social interaction, in the open
field test, LY341495 also blocked the reversing effects of NAC
on the time spent in the center field in VPA-exposed off-
spring (Figure 7C) without affecting the total distance traveled
(Figures 7B,D).
THE EXPRESSION OF THE mGLuR2/3 RECEPTOR IS REDUCED IN
VPA-EXPOSED OFFSPRING
We determined whether the expressions of the mGluR2/3 recep-
tor and Xc− were altered in the VPA-exposed offspring. Two-Way
ANOVA revealed a significant main effect of pre-treatment [VPA
vs. saline, F(1, 20) = 5.493, p < 0.05] in the absence of a main
effect of drug [NAC vs. saline, F(1, 20) = 0.072, p > 0.5], or
a significant pre-treatment x drug interaction [F(1, 20) = 0.59,
p > 0.1) (Figure 8A). These results suggested that the expres-
sion of the mGluR2/3 receptor was significantly lower in the
VPA-exposed group than in the saline-exposed offspring. In
addition, treatment with NAC had no effect on the expres-
sion of the mGluR2/3 receptor. In contrast to the expression
of mGluR2/3, there were no significant effects of pre-treatment
[VPA vs. saline, F(1, 21) = 0.148, p > 0.5] or drug [NAC vs. saline,
F(1, 20) = 3.019, p > 0.05] and no significant pre-treatment x
drug interaction [F(1, 21) = 0.562, p > 0.1] in Xc− expression
among the four groups of rats (Figure 8B).
We also measured the mGluR2 and mGluR3 mRNA levels.
The results revealed that the mGluR2 mRNA level in the VPA-
exposed offspring rats was significantly lower than that in the
saline-exposed control rats (p < 0.05) (Figure 8C). In contrast,
there was no difference between these two groups in terms of
mGluR3 mRNA (p > 0.5) (Figure 8D).
DISCUSSION
We have confirmed that the male VPA-exposed offspring exhib-
ited a deficit in social interaction and increased anxiety in
the EPM and open field tests. Whole-cell recordings revealed
increased frequency of mEPSCs and decreased PPF at the
Frontiers in Behavioral Neuroscience www.frontiersin.org June 2014 | Volume 8 | Article 219 | 5
Chen et al. NAC rescues autism-like phenotypes
FIGURE 4 | Effects of NAC on the amplitude and frequency of mEPSCs
recorded in the LA of VPA-exposed offspring. (A) Sample traces of
mEPSCs taken from slices of Saline/Saline, Saline/NAC, VPA/Saline, and
VPA/NAC rats. mEPSCs were recorded in the LA neurons at a holding
potential of −70mV in the presence of TTX (1µM). Calibration: 30 pA,
100ms. (B,C) Summary plots of the frequency (B) and amplitude (C) of
mEPSCs in the Saline/Saline, Saline/NAC, VPA/Saline, and VPA/NAC rats.
∗∗p < 0.01 vs. VPA/saline. ###p < 0.001 vs. Saline/Saline.
FIGURE 5 | Effects of NAC on the PPF of EPSCs at the thalamo-LA
synapses of the VPA-exposed offspring. (A) Sample traces of the PPF of
EPSCs taken from slices of Saline/Saline, Saline/NAC, VPA/Saline, and
VPA/NAC rats. Sample traces were the average of 3–5 successive
responses. Calibration; 50 pA, 30ms. (B) Plot of the PPF in the
Saline/Saline, Saline/NAC, VPA/Saline, and VPA/NAC rats. ∗p < 0.05,
∗∗p < 0.01 vs. VPA/saline. ##p < 0.01 vs. Saline/Saline.
thalamo-LA synapses from brain slices of VPA-exposed offspring.
The frequency of mEPSCs is a functional index of the number
of glutamate release sites per cell. PPF is generally attributed
to a presynaptic change in release probability that is decreased
FIGURE 6 | NAC-mediated reversal of social interaction deficit in
VPA-exposed offspring is blocked by mGluR2/3 antagonist. (A,B) Rats
of saline-exposed offspring weaned at postnatal day 21. At postnatal day
24, the rats received an intra-amygdala injection of LY341495 (2µg/0.5µl
per side) or saline once per day for 5 days. One hour after the last injection
of LY341495 or saline, the rats were administered the social interaction
test. The duration (A) and frequency (B) of contact between the VPA- and
saline-exposed offspring were measured for 20min. Sample sizes (n):
Saline/Saline n = 4, Saline/LY n = 5. (C,D) Rats of VPA-exposed offspring
weaned at postnatal day 21 were administered an intraperitoneal injection
of NAC (150mg/kg) once per day for 8 days. At postnatal day 24, the rats
received an intra-amygdala injection of LY341495 (2µg/0.5µl per side) or
saline 30min before NAC once per day for 5 days. One hour after the last
injection of LY341495 or saline, the rats were administered the social
interaction test. The duration (A) and frequency (B) of contact between the
VPA- and saline-exposed offspring were measured for 20min. Sample sizes
(n): Saline/Saline n = 9, Saline/LY n = 9. ∗∗∗p < 0.001 vs. NAC/Saline.
when release of the transmitter is increased (Hsia et al., 1998;
Zucker and Regehr, 2002). The observed increased frequency and
increased PPF, coupled with an unaltered amplitude of mEPSCs,
suggest that the presynaptic release mechanism may underlie the
behavioral abnormality in this rat model of autism. The pro-
tein levels of mGluR2/3 were reduced, which was correlated with
the decrease in mGluR2 mRNA. In contrast, mGluR3 mRNA
was unchanged. Thus, these results suggested that mGluR2
might play an important role in the underlying mechanisms
of ASD.
The mechanisms through which NAC reverses the amygdal
presynaptic efficiency of excitatory synaptic transmissions remain
to be explored. Previous studies have implied that NAC affects
glutamate homeostasis at the nucleus accumbens synapse in
cocaine seeking. NAC activated presynatic mGluR2/3 receptors-
mediated depotentiation but not post-synaptic mGluR5 receptor
led to reduce the EPSCs (Kalivas, 2009; Reissner and Kalivas, 2010;
Kupchik et al., 2012). Interestingly, we found in this study that
NAC improved social interaction and ameliorated anxiety-like
behaviors in the VPA-exposed offspring. In addition, NAC treat-
ment reversed the increased frequency of mEPSCs and decreased
the PPF in the VPA-exposed offspring. All these effects could
be blocked by mGluR2/3 receptors antagonist LY341495. The
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FIGURE 7 | NAC-mediated amelioration of anxiety in VPA-exposed
offspring is blocked by mGluR2/3 antagonist. (A,B) Rats of
saline-exposed offspring weaned at postnatal day 24 received an
intra-amygdala injection of LY341495 (2µg/0.5µl per side) once per day for
5 days. Twenty-four hours later, the rats were administered the elevated
plus-maze test. The time spent in the open arms (A) and the distance
traveled (B) were measured for 5min. (C,D) Rats of VPA-exposed offspring
weaned at postnatal day 21 were administered an intraperitoneal injection
of NAC (150mg/kg) once per day for 8 days. At postnatal day 24, the rats
received an intra-amygdala injection of LY341495 (2µg/0.5µl per side)
30min before NAC once per day for 4 days. Twenty-four hours after the last
injection of NAC and LY341495, the rats were administered the elevated
plus-maze test. The time spent in the open arms (C) and the distance
traveled (D) were measured for 5min. ∗p < 0.05 vs. NAC/Saline.
present study was consistent with previous study of addition
disorders, and the results showed that NAC could decrease the
PPF at the thalamo-LA synapses in the VPA-exposed offspring via
activation of presynaptic mGluR2/3 receptors.
We also found that the protein levels of mGluR2/3 and the
mRNA level of mGluR2 were decreased in VPA-exposed off-
spring. Hascup et al. noted that a novel positive allosteric modula-
tor (PAM) of mGluR2 can inhibit the enhanced phasic glutamate
release within the prefrontal cortex in the restraint-stressed rat.
Thus, the PAM of mGluR2 has the potential effect of an anxiolytic
in restraint stress (Hascup et al., 2012). Our study also noted that
the regulation of mGluR2 played dual roles in VPA-exposed off-
spring. Future experiments to investigate the role of mGluR2 in
the ASD model are warranted.
In the present study, we provided the first evidence that
the abnormal behavioral performances and electrophysiologi-
cal characteristics in VPA-exposed offspring could be corrected
after administration of NAC. NAC is the N-acetyl derivative
of the amino acid L-cysteine, which is rapidly oxidized to
cystine in the pro-oxidant milieu of the brain. The cystine-
glutamate antiporter (system Xc−) is responsible for the control
of extracellular glutamate and feedback regulation of glutamate
FIGURE 8 | The expression of the mGluR2/3 receptor is reduced in
VPA-exposed offspring. (A,B) Rats of saline- or VPA-exposed offspring
weaned at postnatal day 21 were administered NAC (150mg/kg, i.p.) or
saline once per day for 7 days. Twenty-four hours after the last injection of
NAC, the amygdala mGluR2/3 (A) and Xc− (B) protein levels were
determined by Western blotting analysis. ∗p < 0.05. (C,D) The mRNA levels
of mGluR2 and mGluR3 were determined by RT-PCR analysis.
release (Baker et al., 2002). NAC administration can activate
the cystine-glutamate antiporter through provision of additional
cystine, thus increasing the extracellular glutamate concentration.
The extracellular glutamate activates metabotropic glutamate
receptors (mGluR2) on presynaptic neurons and reduces vesicu-
lar glutamate neurotransmission. Consistent with this hypothesis,
we found that NAC-mediated reversal of the behavioral pheno-
type was blocked by mGluR2/3 antagonist.
If the reduced expression of mGluR2 underlies the abnormal
behaviors seen in VPA-exposed offspring, then administration of
mGluR2/3 antagonist to normal rats may cause autism-like phe-
notypes. However, this is not the case, as intra-amygdala infusion
of mGluR2/3 antagonist LY341495 had no effect on social interac-
tion (Figure 6A) and the results of the open field test (Figure 7A)
in the saline-exposed offspring. It is likely that the half-life of
LY341495 in the brain pharmacokinetics (4.75 h) (Ornstein et al.,
1998) is too short to produce autism-like behaviors. Future study
with genetic knockdown of mGluR2 may resolve this issue.
In summary, in a rat model of valproate-induced autism,
we found that the protein and mRNA levels of mGluR2 were
reduced concomitant with an increased frequency of mEPSCs and
decreased PPF, which could be corrected by NAC. Thus, med-
ications that could enhance mGluR2 expression and/or reduce
glutamate release in the amygdala might be candidates for the
treatment of ASD.
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